Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
721 Results Found
AHA, Hospital Groups Ask HHS to Renew the COVID-19 Public Health Emergency (PHE)
AHA, hospital groups ask U.S. Department of Health and Human Services Secretary, Xavier Becerra, to renew the COVID-19 public health emergency (PHE).
CDC updates masking guidance; patients cleared to wear N95s
The Centers for Disease Control and Prevention yesterday broadened its masking guidance, enabling visitors of health care facilities to wear N95 masks.
Pfizer asks FDA to authorize second booster for older adults
Pfizer asked the Food and Drug Administration to authorize a second booster dose of its COVID-19 vaccine for adults age 65 and older who received an initial booster of any authorized or approved COVID-19 vaccine, based on data from Israel showing the additional booster reduced infections and severe illness when the omicron variant was circulating.
Report: COVID-19 hospitalizations surged in children under 5 during omicron
Weekly COVID-19-associated hospitalization rates among U.S. infants and children under age 5 have declined since peaking Jan. 8, but peak rates during omicron predominance were about five times those during delta predominance, the Centers for Disease Control and Prevention reported.
FDA extends shelf life for refrigerated J&J COVID-19 vaccine
The Food and Drug Administration recently authorized extending from six to nine months the shelf life for refrigerated Johnson & Johnson COVID-19 vaccine stored at 2-8 degrees Celsius (about 36-46 degrees Fahrenheit), based on data submitted by the company.
Transportation mask mandate extended one month, policy change in works
The Transportation Security Administration will continue to require masks on public transportation through April 18 to protect against COVID-19, as the Centers for Disease Control and Prevention recommends.
CDC: Pfizer vaccine reduces omicron infection risk 31%-59% in children age 5-15
In a study of 1,364 children aged 5-15, two doses of the Pfizer COVID-19 vaccine reduced the risk of omicron infection by 31% in those under 12 and 59% in older children, the Centers for Disease Control and Prevention reported.
HHS updates COVID-19 laboratory reporting requirements
Effective April 4, the Department of Health and Human Services will no longer require COVID-19 testing facilities to report negative results for tests authorized for use under a Clinical Laboratory Improvement Amendment certificate of waiver, the Centers for Disease Control and Prevention reports.
CDC reports on early COVID-19 vaccine access, coverage for children age 5-11
An estimated 28% of children aged 5-11 received a first dose of the Pfizer COVID-19 vaccine between Nov. 1 and Jan. 18, while 19% received a second dose, according to a report released by the Centers for Disease Control and Prevention
Medicare releases billing code for preventive COVID-19 antibody treatment
The Centers for Medicare & Medicaid Services has released a Medicare payment code effective Feb. 24 for administering the combination monoclonal antibody therapy Evusheld to prevent COVID-19 in certain patients.